Medical Devices

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

With two new powerhouse executives, Phoenix Children's is poised to execute a bold new vision for pediatric care, targeting workforce, growth, and community impact.

ImmunoBrain's novel immunotherapy for Alzheimer's avoids key safety issues of other drugs and shows positive biomarker data in a Phase 1b trial.

With Saumay Kumar as new CEO and Timothy Kelley as CSO, TeleRay is betting a dual-leadership model will accelerate growth and define the future of virtual care.

Ractigen's RAG-01 advances with NMPA approval, using RNA activation to fight bladder cancer by targeting a previously 'undruggable' gene.

Quebec’s new budget maintains support for its vital life sciences sector, but industry leaders warn new tax rules could hinder innovation for small firms.

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

After his own diagnosis, golfer Brian Gay advocates for GentleCure, a non-surgical option with a 99% cure rate that kept him on the course.

A new partnership signals a major shift in the aesthetics market, blending private equity scale with a new focus on university-backed provider education.

Micro-Tech Endoscopy brings key GI products in-house as CONMED exits the market. The move ensures clinician access and strengthens Micro-Tech’s global position.

With a major Series B financing, Crossbow advances its TCR-mimetic therapies, aiming to unlock a new frontier in the fight against a broad range of cancers.

JenaValve's Trilogy system gains historic FDA approval, offering a new, minimally invasive option for high-risk patients with a life-threatening heart condition.

CareCloud unveils its next-gen MAP App, blending AI with trusted HFMA benchmarks to help hospitals navigate complex financial challenges and boost efficiency.

Swiss firm H55's flight-proven batteries are fast-tracking a new hybrid-electric regional aircraft demonstrator, promising a 30% leap in fuel efficiency.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

A new partnership will leverage genetically engineered mice to create novel antibody drugs, potentially unlocking treatments for cancer and brain diseases.

A new AI-powered blood test for early liver cancer detection is now accessible nationwide through Quest Diagnostics, aiming to improve dismal screening rates.

InflaRx announces a late-breaking presentation on its Phase 3 trial for vilobelimab, offering potential new hope for pyoderma gangrenosum patients.

ACTO's new AI suite automates workflows, promising to boost efficiency and compliance for pharma and medtech field professionals while keeping humans in control.

With a new CEO and Chair, IsomAb is advancing a disease-modifying drug for 9 million angina patients, eyeing a major Series A fundraise.